Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_assertion type Assertion NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_head.
- NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_assertion description "[The PPARgamma-modulating drug Troglitazone downregulates the anti-apoptotic FLIP protein and sensitizes glioblastoma cells to apoptosis induced by the death ligand TRAIL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_provenance.
- NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_assertion evidence source_evidence_literature NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_provenance.
- NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_assertion SIO_000772 19158480 NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_provenance.
- NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_assertion wasDerivedFrom befree-2016 NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_provenance.
- NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_assertion wasGeneratedBy ECO_0000203 NP715783.RAzWJjDbrXbwkKm_dMIu9Al9OR19Q7anVUy0fhYn6zgtA130_provenance.